SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Trovagene Inc., a local firm that makes liquid biopsy tests, is collaborating with the University of Southern California’s Norris Comprehensive Cancer Center on the best way to use its tests in the clinic, the company announced Tuesday.
Coronado-based Presbyopia Therapies LLC has raised nearly $4 million in equity financing, according to a recent form filed with the Securities and Exchange Commission.
Sorrento Therapeutics Inc., a local biopharmaceutical company, has landed a partnership with French pharmaceutical giant Servier to develop products based on Sorrento’s tech.
Illumina Inc. has settled a patent-infringement lawsuit with New York-based Enzo Biochem subsidiary Enzo Life Sciences for $21 million, according to several wire services.
Two major bond credit rating services have weighed in on the fiscal health of Palomar Health, the public hospital district announced.
From the polio vaccine to the MRI scanner, America has a rich history of developing lifesaving medicines. The Trans-Pacific Partnership (TPP) trade agreement is important to small pharmaceutical companies like mine and our ability to bring the next generation of medicines to the global marketplace.
It’s tough times for Regulus Therapeutics Inc. Once a local biotech heavyweight valued at nearly $1 billion, the San Diego company’s shares have fallen dramatically over the last 18 months. The company’s valuation is hovering around $170 million after the latest blow: a FDA-ordered suspension on Regulus’ lead product candidate, RG-101.
BIOTECH: Halozyme Gets Creative in Pursuit of Cash
In today’s market, with valuations down and investors wary, it’s critical for biotechs to get creative when looking for cash to fuel research.
Germany-based Curetis GmbH has opened a North American subsidiary in San Diego and named Christopher M. Bernard as its leader.
Trovagene Inc., a San Diego-based company that makes liquid biopsy tests, announced that it is partnering with the University of Michigan Comprehensive Cancer Center on a multi-phase research collaboration to assess whether Trovgene’s Trovera KRAS ctDNA test can be used to detect early-stage pancreatic cancers.
Cidara Therapeutics Inc., a San Diego-based biotechnology company developing anti-fungal medications, announced the addition of Neil Abdollahian and Matt Onaitis to the executive management team. Abdollahian was named chief business officer and Onaitis was appointed chief financial officer and general counsel.
San Diego’s Ignyta Inc. has secured $42 million in loan from Silicon Valley Bank and Oxford Finance.
San Diego drugmaker Arena Pharmaceuticals is laying off 100 employees, or 73 percent of its workforce, as part of a strategic shift in focus.
National University, a private, nonprofit university, is joining with a Scripps Health-affiliated physicians group to make it easier for students studying health care administration and public health to land internships from among hundreds of local physician groups, the university announced.
NuVasive Inc., a San Diego-based medical device company, announced that it has settled its patent infringement dispute with Medtronic.